» Articles » PMID: 37175536

Molecular and Epigenetic Aspects of Opioid Receptors in Drug Addiction and Pain Management in Sport

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 May 13
PMID 37175536
Authors
Affiliations
Soon will be listed here.
Abstract

Opioids are substances derived from opium (natural opioids). In its raw state, opium is a gummy latex extracted from . The use of opioids and their negative health consequences among people who use drugs have been studied. Today, opioids are still the most commonly used and effective analgesic treatments for severe pain, but their use and abuse causes detrimental side effects for health, including addiction, thus impacting the user's quality of life and causing overdose. The mesocorticolimbic dopaminergic circuitry represents the brain circuit mediating both natural rewards and the rewarding aspects of nearly all drugs of abuse, including opioids. Hence, understanding how opioids affect the function of dopaminergic circuitry may be useful for better knowledge of the process and to develop effective therapeutic strategies in addiction. The aim of this review was to summarize the main features of opioids and opioid receptors and focus on the molecular and upcoming epigenetic mechanisms leading to opioid addiction. Since synthetic opioids can be effective for pain management, their ability to induce addiction in athletes, with the risk of incurring doping, is also discussed.

Citing Articles

Opioid and Cannabinoid Systems in Pain: Emerging Molecular Mechanisms and Use in Clinical Practice, Health, and Fitness.

Secondulfo C, Mazzeo F, Pastorino G, Vicidomini A, Meccariello R, Operto F Int J Mol Sci. 2024; 25(17).

PMID: 39273354 PMC: 11394805. DOI: 10.3390/ijms25179407.


Unraveling the Hippocampal Molecular and Cellular Alterations behind Tramadol and Tapentadol Neurobehavioral Toxicity.

Soares-Cardoso C, Leal S, Sa S, Dantas-Barros R, Dinis-Oliveira R, Faria J Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931463 PMC: 11206790. DOI: 10.3390/ph17060796.


Neuronal dysfunction and gene modulation by non-coding RNA in Parkinson's disease and synucleinopathies.

Meccariello R, Carlo Bellenchi G, Pulcrano S, DAddario S, Tafuri D, Mercuri N Front Cell Neurosci. 2024; 17:1328269.

PMID: 38249528 PMC: 10796818. DOI: 10.3389/fncel.2023.1328269.


Molecular Advances on Cannabinoid and Endocannabinoid Research.

Meccariello R Int J Mol Sci. 2023; 24(16).

PMID: 37628940 PMC: 10454180. DOI: 10.3390/ijms241612760.


Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity.

Vasincu A, Rusu R, Ababei D, Neamtu M, Arcan O, Macadan I Biomedicines. 2023; 11(6).

PMID: 37371762 PMC: 10296259. DOI: 10.3390/biomedicines11061667.

References
1.
Salim U, Kumar A, Kulshreshtha R, Vivekanandan P . Biogenesis, characterization, and functions of mirtrons. Wiley Interdiscip Rev RNA. 2021; 13(1):e1680. DOI: 10.1002/wrna.1680. View

2.
Schenone S, Bruno O, Ranise A, Brullo C, Bondavalli F, Filippelli W . 2-aryl-3-phenylamino-4,5-dihydro-2h-benz[g]indazoles with analgesic activity. Farmaco. 2003; 58(9):845-9. DOI: 10.1016/S0014-827X(03)00142-3. View

3.
Izadpanah M, Seddigh A, Barough S, Shahzadeh Fazeli S, Ai J . Potential of Extracellular Vesicles in Neurodegenerative Diseases: Diagnostic and Therapeutic Indications. J Mol Neurosci. 2018; 66(2):172-179. DOI: 10.1007/s12031-018-1135-x. View

4.
Margolis E, Lock H, Chefer V, Shippenberg T, Hjelmstad G, Fields H . Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proc Natl Acad Sci U S A. 2006; 103(8):2938-42. PMC: 1413839. DOI: 10.1073/pnas.0511159103. View

5.
Bai X, Huang Y, Zhang K, Huang W, Mu Y, Li Y . CircNf1-mediated CXCL12 expression in the spinal cord contributes to morphine analgesic tolerance. Brain Behav Immun. 2022; 107:140-151. DOI: 10.1016/j.bbi.2022.09.018. View